The Study of the Immunogenity and Reactogenity of Trivalent, Purified, Inactivated Influenza Vaccine for Parenteral Administration in Adults, for the 2010-2011 Season, Produced by Cantacuzino National Institute of Research and Development for Microbiology and Immunology

Cantacuzino National Institute of Research and Development for Microbiology and Immunology0 个研究点目标入组 0 人开始时间: 2011年6月24日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Able to give the written informed consent
•Able to understand and to follow all the phases and the procedures of this study
•Age 18-60 or >60 years and haven't been vaccinated against influenza in the previous year
•Availability for all the visits of this study
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Allergy to eggs
•Allergy to thyomersal
•Guillain-Barre syndrome in personal records
•Less than 30 days from the participation or present inclusion in another clinical trial
•Receiving parenteral Immunoglobulins in the 30 days previous to assessment for the inclusion in the study
•Pregnant or nursing
•Non-compensated diseases
•Fever or other symptoms that may cause confusion with postvaccinal reactions
•Autoimmune disease, immunodeficiency
•Immunosupressant treatment: corticoids, chemotherapy, radiotherapy
•Drugs or alcohol abuse
•HIV, Treponema pallidum, TBC, HBV, HCV infection
•Contagious disease contact in personal records

发起方

Cantacuzino National Institute of Research and Development for Microbiology and Immunology